Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patients With Advanced or Metastatic Solid Tumors × Epirubicin × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2 Patients With Advanced or Metastatic Solid Tumors 1

Interventions

temsirolimus 1 tegafur-gimeracil-oteracil 1 S 1 (combination) 1 Oxaliplatin 1 Epirubicin 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02867397 2016-08-15

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

Disphar International B.V.

Phase 1 Completed

Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡